Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-10-28
1985-12-03
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514369, 514376, 548147, 548216, 548313, C07D27734, C07D23338, C07D26344, A61K 31415
Patent
active
045566704
ABSTRACT:
Spiro-oxazolidones, -thiazolidones and -imidazolidones are disclosed which are useful as aldose reductase inhibitors and as therapeutic agents for the treatment of complications arising from diabetes. Pharmaceutical compositions containing the spiro compounds and a method of treating diabetic complications are also disclosed.
REFERENCES:
patent: 2872454 (1959-02-01), Waring
patent: 3532744 (1970-10-01), Fletcher, III et al.
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 3985888 (1976-10-01), Carr et al.
patent: 4117230 (1978-09-01), Sargas
patent: 4130714 (1978-12-01), Sargas
patent: 4181729 (1980-01-01), Sarges et al.
patent: 4200642 (1980-04-01), Schnur
patent: 4226875 (1980-10-01), Schnur
patent: 4248882 (1981-02-01), Sargas et al.
patent: 4307108 (1981-12-01), Belletire et al.
J. A. Faust et al., "Anticonvulsants: Spirohydantoins and Derivatives of Tetrahydronaphthalene," J. Amer. Pharm. Assoc., 44, 118-124, (1957).
H. R. Henze et al., "The Behavior of Certain 1,3-Indandiones in Attempted Hydantoin Formation," J. Org. Chem., 17, 4-13, (1952).
R. C. Schnur et al., "Spiro Oxazolidinedione Aldose Reductase Inhibitors," J. Med. Chem., 25, 1451-4, (1982).
R. Sarges et al., "Synthesis of Optically Active Spirohydantoins by Asymetric Induction. Hydantoin Formation from Amino Nitriles and Chlorosulfonyl Isocyanate," J. Org. Chem., 47, 4081-85, (1982).
Gerstl Robert
Knuth Charles J.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Spiro-3-hetero-azolones for treatment of diabetic complications does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro-3-hetero-azolones for treatment of diabetic complications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-3-hetero-azolones for treatment of diabetic complications will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1394948